Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP634816.RAS_W7Kq2dUJY8vUGjFiHMKL-5W0wvUzmAVIt5ZDHGB3Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP634816.RAS_W7Kq2dUJY8vUGjFiHMKL-5W0wvUzmAVIt5ZDHGB3Q130_assertion type Assertion NP634816.RAS_W7Kq2dUJY8vUGjFiHMKL-5W0wvUzmAVIt5ZDHGB3Q130_head.
- NP634816.RAS_W7Kq2dUJY8vUGjFiHMKL-5W0wvUzmAVIt5ZDHGB3Q130_assertion wasGeneratedBy ECO_0000203 NP634816.RAS_W7Kq2dUJY8vUGjFiHMKL-5W0wvUzmAVIt5ZDHGB3Q130_provenance.
- NP634816.RAS_W7Kq2dUJY8vUGjFiHMKL-5W0wvUzmAVIt5ZDHGB3Q130_assertion wasDerivedFrom befree-20150227 NP634816.RAS_W7Kq2dUJY8vUGjFiHMKL-5W0wvUzmAVIt5ZDHGB3Q130_provenance.
- NP634816.RAS_W7Kq2dUJY8vUGjFiHMKL-5W0wvUzmAVIt5ZDHGB3Q130_assertion SIO_000772 10978257 NP634816.RAS_W7Kq2dUJY8vUGjFiHMKL-5W0wvUzmAVIt5ZDHGB3Q130_provenance.
- NP634816.RAS_W7Kq2dUJY8vUGjFiHMKL-5W0wvUzmAVIt5ZDHGB3Q130_assertion evidence source_evidence_literature NP634816.RAS_W7Kq2dUJY8vUGjFiHMKL-5W0wvUzmAVIt5ZDHGB3Q130_provenance.
- NP634816.RAS_W7Kq2dUJY8vUGjFiHMKL-5W0wvUzmAVIt5ZDHGB3Q130_assertion description "[No significant differences were found in the therapeutic response of PON1 activity between genotype groups (8.5% and 11.1% increase for QQ homozygous and R-carrier FH patients, respectively, and 12.7% and 9.5% increase for LL homozygotes and M carriers, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP634816.RAS_W7Kq2dUJY8vUGjFiHMKL-5W0wvUzmAVIt5ZDHGB3Q130_provenance.